Free Trial

93,162 Shares in Amdocs Limited (NASDAQ:DOX) Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Amdocs logo with Computer and Technology background

Key Points

  • Universal Beteiligungs und Servicegesellschaft mbH has acquired a new stake in Amdocs Limited, purchasing 93,162 shares, valued at approximately $8.5 million, increasing its ownership to about 0.08% of the company.
  • Institutional investors hold a significant 92.02% of Amdocs' stock, with several hedge funds, including Alyeska Investment Group and Wellington Management, increasing their positions by substantial percentages in the last quarter.
  • Amdocs reported a quarterly earnings per share of $1.78, surpassing analyst expectations, while projecting an annual earnings per share of 6.21 for the current year amidst a 9.4% decline in revenue compared to last year.
  • Interested in Amdocs? Here are five stocks we like better.

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Amdocs Limited (NASDAQ:DOX - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 93,162 shares of the technology company's stock, valued at approximately $8,524,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.08% of Amdocs as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of DOX. OneDigital Investment Advisors LLC increased its holdings in shares of Amdocs by 20.8% in the 1st quarter. OneDigital Investment Advisors LLC now owns 3,026 shares of the technology company's stock worth $277,000 after buying an additional 521 shares during the last quarter. Farther Finance Advisors LLC grew its position in Amdocs by 17.5% in the first quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock worth $90,000 after acquiring an additional 147 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its stake in Amdocs by 7.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,738 shares of the technology company's stock worth $616,000 after acquiring an additional 490 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of Amdocs by 55.0% in the 4th quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after purchasing an additional 208 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in shares of Amdocs by 16.1% in the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock valued at $261,756,000 after purchasing an additional 426,035 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on DOX. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a report on Saturday, June 7th. Wolfe Research started coverage on shares of Amdocs in a research report on Tuesday, July 8th. They set an "outperform" rating on the stock. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus price target of $105.33.

Check Out Our Latest Stock Analysis on Amdocs

Amdocs Trading Up 0.1%

NASDAQ:DOX traded up $0.10 during mid-day trading on Tuesday, hitting $86.92. 290,591 shares of the stock traded hands, compared to its average volume of 691,692. The stock has a market capitalization of $9.81 billion, a price-to-earnings ratio of 18.29, a PEG ratio of 1.45 and a beta of 0.52. Amdocs Limited has a 52 week low of $78.61 and a 52 week high of $95.41. The firm's 50 day moving average is $91.13 and its two-hundred day moving average is $88.66. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, beating the consensus estimate of $1.71 by $0.07. The company had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The firm's revenue was down 9.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.56 EPS. On average, equities research analysts predict that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Monday, June 30th were paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.43%. The ex-dividend date of this dividend was Monday, June 30th. Amdocs's dividend payout ratio is presently 44.42%.

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines